• About us
• Contact

Advertisement

Organisation › Details

Enamine Ltd. (UA)

Established in Kiev in 1991, Enamine is a medicinal chemistry driven company, provider of innovative screening libraries, building blocks, comprehensive chemistry support in hit development, and integrated drug discovery services. Enamine’s design and synthesis capabilities allow the addition of more than 250,000 new organic compounds to its catalogue each year. Enamine offers collaborative expertise to exclusively design and supply libraries of new, potentially bioactive organic compounds. Enamine serves the pharmaceutical, agrochemical, cosmetic, nutritional and petrochemical industries. *

 

	Start	1991-01-01 established
	Industry	chemical services
	Industry 2	chemical compound library (production)
	Person	Tolmachov, Andrey (Enamine 202203 CEO + Founder)
	Person 2	Bossert, Michael (Enamine Ltd 201201 Business Development Director)
	Region	Kyiv (Kiev)
	Country	Ukraine
	Street	23 Alexandra Matrosova Street
	City	01103 Kiev
	Tel	+38-44-537-3218
		Address record changed: 2024-01-05
Basic data	Employees	D: 101 to 500 (2011-07-19)
		* Document for »About Section«:
		Record changed: 2024-02-24

Advertisement

More documents for Enamine Ltd. (UA)

• [1] Cresset Biomolecular Discovery Ltd.. (2/21/24). "Press Release: Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology". Cambridge....
• [2] Enamine Ltd.. (1/11/24). "Press Release: Enamine and SyntheticGestalt to Collaborate on the Creation of AI-based Model to Facilitate Drug Discovery". Tokyo & Kyiv....
• [3] Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried....
• [4] Enamine Ltd.. (5/22/23). "Press Release: Enamine Launches a New Chemistry Site in Germany". Kyiv....
• [5] Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov"....
• [6] Enamine Ltd.. (2/24/21). "Press Release: Enamine Extend Collaboration with Prominent Swiss Biotech". Kyiv....
• [7] Atomwise, Inc.. (6/24/19). "Press Release: Atomwise and Enamine to Advance Pediatric Oncology with the World’s First and Largest Ten Billion Compound Virtual Screen". San Francisco, CA & Kiev....
• [8] Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev....
• [9] Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev....
• [10] Enamine Ltd.. (6/19/18). "Press Release: Enamine and TBD Biodiscovery Collaborate to Provide GMP-based Services". Kiev & Tartu....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.